Tumour suppressor menin is essential for development of the pancreatic endocrine cells

Journal of Endocrinology

Volumn 199, Issue 2, 2008, Pages 287-298

  Fontanière, Sandra ^a,b   Duvillié, Bertrand ^c   Scharfmann, Raphaël ^c   Carreira, Christine ^a   Wang, Zhao Qi ^b,d,e   Zhang, Chang Xian ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSERM   (France)

^d FRITZ LIPMANN INSTITUTE   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; METHIONINE; NEUROGENIN 3; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; EMBRYO; ENDOCRINE CELL; HOMOZYGOSITY; KNOCKOUT MOUSE; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENDOCRINE CELLS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PANCREAS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 56849092636     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0289     Document Type: Article

References (43)

1. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM et al. 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 143-152.
2. Ahlgren U, Jonsson J & Edlund H 1996 The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/ PDX1-deficient mice. Development 122 1409-1416.
3. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U & Edlund H 1999 Notch signalling controls pancreatic cell differentiation. Nature 400 877-881.
4. Attali M, Stetsyuk V, Basmaciogullari A, Aiello V, Zanta-Boussif MA, Duvillie B & Scharfmann R 2007 Control of β-cell differentiation by the pancreatic mesenchyme. Diabetes 56 1248-1258.
5. Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ & Zhang CX 2003 a Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mechanisms of Development 120 549-560.
6. Bertolino F, Tong WM, Galendo D. Wang ZQ & Zhang CX 2003b Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Molecular Endocrinology 17 1880-1892.
7. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX & Wang ZQ 2003c Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research 63 4836-4841.
8. Bhushan A, Itoh N, Kato S, Thiery JP, Czernichow P, Bellusci S & Scharfmann R 2001 Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128 5109-5117.
9. Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF & Hayward NK 2004 Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Molecular and Cellular Biology 24 3125-3131.
10. Cano DA, Murcia NS, Pazour GJ & Hebrok M 2004 Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization. Development 131 3457-3467.
11. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA et al. 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Molecular and Cellular Biology 23 6075-6085.
12. Duvillie B, Attali M, Aiello V, Quemeneur E & Scharfmann R 2003 Label-retaining cells in the rat pancreas: location and differentiation potential in vitro. Diabetes 52 2035-2042.
13. Duvillie B, Attali M, Bounacer A, Ravassard P, Basmaciogullari A & Scharfmann R 2006 The mesenchyme controls the timing of pancreatic beta-cell differentiation. Diabetes 55 582-589.
14. Edlund H 2002 Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nature Reviews. Genetics 3 524-532.
15. Gradwohl G, Dierich A, LeMeur M & Guillemot F 2000 Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. PNAS 97 1607-1611.
16. Guz Y, Montminy MR, Stein R, Leonard J, Gamer LW, Wright CV & Teitelman G 1995 Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121 11-18.
17. Heiser PW, Lau J, Taketo, MM, Herrera PL & Hebrok M 2006 Stabilization of beta-catenin impacts pancreas growth. Development 133 2023-2032.
18. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ et al. 2001 The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 4917-4925.
19. Herrera PL 2000 Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 127 2317-2322.
20. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA et al. 2004 Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Molecular Cell 13 587-597.
21. Jacquemin P, Durviaux SM, Jensen J, Godfraind C, Gradwohl G, Guillemot F, Madsen OD, Carmeliet P, Dewerchin M, Collen D et al. 2000 Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Molecular and Cellular Biology 20 4445-4454.
22. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibasin M, Kageyama R, Guillemot F, Setup P & Madsen OD 2000 Control of endodermal endocrine development by Hes-1. Nature Genetics 24 36-44.
23. Jonsson J, Carlsson L, Edlund T & Edlund H 1994 Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371 606-609.
24. Kaji H, Canaff L, Lebrun JJ, Goltzman D & Hendy GN 2001 Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. PNAS 98 3837-3842.
25. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH & Kim SK 2007 Meran controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318 806-809.
26. Kim H, Lee JE, Cho EJ, Liu JO & Youn HD 2003 Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Research 63 6135-6139.
27. Larsson C, Skogseid B, Oberg K, Nakamura Y & Nordenskjold M 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 85-87.
28. Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J, Mirmira RG & German MS 2001 Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 50 928-936.
29. Lin SY & Elledge SJ 2003 Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 881-889.
30. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME & Jacks T 2004 Cell type-specific effects of Rb deletion in the murine retina. Genes and Development 18 1681-1694.
31. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Don Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D et al. 2005 Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. PNAS 102 749-754.
32. Namihira H, Sato M, Murao K, Cao WM, Matsubara S, Imachi H, Niimi M, Dobashi H, Wong NC & Ishida T 2002 The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity. Journal of Molecular Endocrinology 29 297-304.
33. Pierreux CE, Poll AV, Kemp CR, Clotman F, Maestro MA, Cordi S, Ferrer J, Leyns L, Rousseau GG & Lemaigre FP 2006 The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse. Gastroenterology 130 532-541.
34. Ravassard P, Chatail F, Mallet J & Icard-Liepkalns C 1997 Relax, a novel rat bHLH transcriptional regulator transiently expressed in the ventricular proliferating zone of the developing central nervous system. Journal of Neuroscience Research 48 146-158.
35. Sayo Y, Murao K, Imachi H, Cao WM, Sato M, Dobashi H, Wong NC & Ishida T 2002 The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology 143 2437-2440.
36. Smart NG, Apelqvist AA, Gu X, Harmon EB, Topper JN, MacDonald RJ & Kim SK 2006 Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-β signaling and induces reversible diabetes mellitus. PLOS Biology 4 e39.
37. Sowa H, Kaji H, Canaff L, Hendy GN, Tsukamoto T, Yamaguchi T, Miyazono K, Sugimoto T & Chihara K 2003 Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. Journal of Biological Chemistry 278 21058-21069.
38. Sowa H, Kaji H, Kitazawa R, Kitazawa S, Tsukamoto T, Yano S, Tsukada T, Canaff L, Hendy GN, Sugimoto T et al. 2004 Menin inactivation leads to loss of transforming growth factor beta inhibition of parathyroid cell proliferation and parathyroid hormone secretion. Cancer Research 64 2222-2228.
39. Stoffers DA, Ferrer J, Clarke WL & Habener JF 1997 Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics 17 138-139.
40. Thakker RV 1998 Multiple endocrine neoplasia -syndromes of the twentieth century. Journal of Clinical Endocrinology and Metabolism 83 2617-2620.
41. Wilson ME, Scheel D & German MS 2003 Gene expression cascades in pancreatic development. Mechanisms of Development 120 65-80.
42. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W & Cleary ML 2004 Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Molecular and Cellular Biology 24 5639-5649.
43. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M & Cleary ML 2005 The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 207-218.